US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
In trading on Wednesday, communication services shares fell by 0.7%.U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 20 points on Wednesday.
美国股市今早交投不一，道琼斯指数周三上涨约20点。
The Dow traded up 0.05% to 42,762.18 while the NASDAQ fell 0.06% to 18,305.30. The S&P 500 also fell, dropping, 0.07% to 5,811.21.
道琼斯指数上涨0.05%，至42,762.18点，纳斯达克指数下跌0.06%，至18,305.30点。标准普尔500指数也下跌0.07%，至5,811.21点。
Leading and Lagging Sectors
Financials shares jumped by 0.7% on Wednesday.
领涨与跌幅最大的板块：
周三，金融股上涨了0.7%。
In trading on Wednesday, communication services shares fell by 0.7%.
周三交易中，通讯服务股下跌了0.7%。
Top Headline
头条新闻：
On Wednesday, Abbott Laboratories (NYSE:ABT) reported better-than-expected third-quarter results.
周三，雅培（纽交所：ABT）公布了好于预期的第三季度业绩。
The company posted sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20.
该公司报告的营业额为106.4亿美元，同比增长4.9%，超过了105.5亿美元的共识。雅培的调整后每股稀释收益为1.21美元，超过了分析师预估的1.20美元。
Equities Trading UP
股票上涨：
- 180 Life Sciences Corp (NASDAQ:ATNF) shares shot up 668% to $11.73. 180 Life Sciences interim CEO said that the company is planning to enter the online gaming industry with its newly acquired gaming technology platform.
- Shares of Santech Holdings Limited (NASDAQ:STEC) got a boost, surging 592% to $2.50.
- Versus Systems Inc. (NASDAQ:VS) shares were also up, gaining 422% to $5.90 after the company announced a $2.5 million investment and licensing agreement with ASPIS.
- 180 life sciences 公司 (纳斯达克:ATNF) 的股价飙升668%，达到11.73美元。180 life sciences 的代理CEO表示，公司计划利用其新获得的游戏技术平台进入在线arvr游戏行业。
- Santech Holdings Limited 的股票 (纳斯达克:STEC) 大涨592%，涨至2.50美元。
- Versus Systems Inc. (纳斯达克:VS) 的股价也上涨，涨幅达422%，达到5.90美元，此前该公司宣布与ASPIS达成一项250万美元的投资和许可协议。
Equities Trading DOWN
股票下跌：
- Bright Minds Biosciences Inc (NASDAQ:DRUG) shares dropped 39% to $23.39. Firefly Neuroscience collaborated with Bright Minds Biosciences to analyze the data from its positive Phase 1 study using its Artificial Intelligence.
- Shares of Silvaco Group, Inc. (NASDAQ:SVCO) were down 28% to $7.94 after the company reported a decline in orders from Asia during third quarter and cut its FY24 revenue outlook.
- Zapata Computing Holdings Inc. (NASDAQ:ZPTA) was down, falling 26% to $0.09.
- Bright Minds Biosciences Inc (纳斯达克:DRUG) 的股价下跌了39%，跌至23.39美元。Firefly Neuroscience 与 Bright Minds Biosciences 合作，分析了其人工智能在积极第一阶段研究中的数据。
- Silvaco Group, Inc. (纳斯达克:SVCO) 的股价下跌了28%，跌至7.94美元，此前该公司报告称在第三季度从亚洲地区订单下降，并削减了FY24年的营业收入展望。
- Zapata Computing Holdings Inc. (纳斯达克:ZPTA) 下跌了26%，跌至0.09美元。
Commodities
In commodity news, oil traded down 0.1% to $70.53 while gold traded up 0.8% at $2,700.00.
商品杂项
在商品新闻中，油价下跌0.1%，至70.53美元，黄金上涨0.8%，至2,700.00美元。
Silver traded up 1.8% to $32.325 on Wednesday, while copper rose 0.8% to $4.3725.
白银周三上涨1.8%，至32.325美元，铜上涨0.8%，至4.3725美元。
Euro zone
欧元区：
European shares were mixed today. The eurozone's STOXX 600 slipped 0.2%, Germany's DAX slipped 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 gained 0.9%.
欧洲股市今日走势不一。欧元区的STOXX 600下跌0.2%，德国的DAX下跌0.2%，法国的CAC 40下跌0.5%。西班牙的IBEX 35指数上涨0.4%，而伦敦的FTSE 100上涨0.9%。
Asia Pacific Markets
亚太市场
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 1.83%, Hong Kong's Hang Seng Index falling 0.16%, China's Shanghai Composite Index gaining 0.05% and India's BSE Sensex falling 0.39%.
亚洲股市周三大多收低，日本的日经225指数下跌1.83%，香港的恒生指数下跌0.16%，中国的上海综合指数上涨0.05%，印度的北交所 Sensex指数下跌0.39%。
Economics
经济学
- U.S. mortgage applications fell by 17% from the previous week during the second week of October.
- Export prices in the U.S. declined by 0.7% month-over-month in September, exceeding market estimates of a 0.4% fall.
- Import prices declined by 0.4% from the previous month in September.
- 美国按揭申请在十月份的第二周较上周下降了17%。
- 美国出口价格在九月份环比下降了0.7%，超过市场预期的0.4%下跌。
- 进口价格在九月份较上月下降了0.4%。
Now Read This:
现在阅读这个：
- Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
- 吉姆·克雷默：'我们需要更多的铀'，推荐这只股票；称诺和诺德“不及大型制药公司对手”
译文内容由第三方软件翻译。
